|
|
Volumn 10, Issue 1, 2015, Pages 143-147
|
|
A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)
a
|
|
Author keywords
NSCLC; Poor risk; Stage III
|
|
Indexed keywords
CARBOPLATIN;
ERLOTINIB;
PACLITAXEL;
ANTINEOPLASTIC AGENT;
QUINAZOLINE DERIVATIVE;
ADULT;
AGED;
ANEMIA;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER RISK;
CANCER SURVIVAL;
CHEMOTHERAPY INDUCED ANEMIA;
CHEMOTHERAPY INDUCED NAUSEA AND VOMITING;
COMPUTER ASSISTED RADIOTHERAPY;
DIARRHEA;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG TOLERABILITY;
ESOPHAGITIS;
FATIGUE;
FEBRILE NEUTROPENIA;
FEMALE;
HUMAN;
INDUCTION CHEMOTHERAPY;
INOPERABLE CANCER;
LUNG INFECTION;
MAJOR CLINICAL STUDY;
MALE;
MULTIPLE CYCLE TREATMENT;
NAUSEA AND VOMITING;
NEUTROPENIA;
NON SMALL CELL LUNG CANCER;
OVERALL SURVIVAL;
PHASE 2 CLINICAL TRIAL;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
RADIATION INDUCED EMESIS;
RASH;
THERAPY EFFECT;
THORACIC RADIOTHERAPY;
THROMBOCYTOPENIA;
TREATMENT DURATION;
ADJUVANT RADIOTHERAPY;
CANCER STAGING;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIAL;
LUNG NEOPLASMS;
MIDDLE AGED;
MULTICENTER STUDY;
PATHOLOGY;
RADIOTHERAPY DOSAGE;
VERY ELDERLY;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
ERLOTINIB HYDROCHLORIDE;
FEMALE;
HUMANS;
INDUCTION CHEMOTHERAPY;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PACLITAXEL;
QUINAZOLINES;
RADIOTHERAPY DOSAGE;
RADIOTHERAPY, ADJUVANT;
|
|
EID: 84926406754
PISSN: 15560864
EISSN: 15561380
Source Type: Journal
DOI: 10.1097/JTO.0000000000000347 Document Type: Article |
|
Times cited : (49)
|
|
References (8)
|
